英文名稱 Anti-CCL1/TCA3/I-309

中文名稱 嗜酸粒細(xì)胞趨化蛋白CCL1抗體

濃 度 1mg/1ml

規(guī) 格 0.1ml/100μg 0.2ml/200μg

抗體來(lái)源 Rabbit

交叉反應(yīng) Human, Mouse, Rat, Pig, Rabbit

產(chǎn)品類型 一抗

研究領(lǐng)域 細(xì)胞生物 免疫學(xué) 信號(hào)轉(zhuǎn)導(dǎo)

蛋白分子量 predicted molecular weight: 10kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from humanCCL1 (12-30aa)

亞 型 IgG

純化方法 affinity purified by Protein A

儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soiumzde

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件  Store at -20 °C for one year.

別 名 C-C motif chemokine 1 precursor; chemokine (C-Cmotif) ligand 1; BF534335; I-309; Scya1; CCL1; Chemokine CC Motif Ligand 1;inflammatory cytokine I-309; P500; SCYA1; SISe; small inducible cytokine A1; Tlymphocyte secreted protein I-309; TCA3